Home
Ajanta Pharma Ltd Board of Directors
Board of Directors at Ajanta Pharma Ltd
Independent Director
Independent Director
Independent Director
Vice President & CS
Independent Director
Key Highlights
- Mannalal B Agrawal continues to serve as the Chairman (Non-Executive) in 2024, maintaining the same position as in the previous year.
- Madhusudan B Agrawal continues to serve as the Vice Chairman in 2024, maintaining the same position as in the previous year.
- Yogesh Agrawal continues to serve as the Managing Director in 2024, maintaining the same position as in the previous year.
- Chandrakanth M Khetan continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.
- Gaurang Shah continues to serve as the Vice President & CS in 2024, maintaining the same position as in the previous year.

Ajanta Pharma Ltd
NSE: AJANTPHARM
Share Price
Last Ten Days Market Price
Date | |
---|---|
08 Apr 2025 | 2491.9 |
07 Apr 2025 | 2374.4 |
04 Apr 2025 | 2490.75 |
03 Apr 2025 | 2621.65 |
02 Apr 2025 | 2618.1 |
01 Apr 2025 | 2615.8 |
28 Mar 2025 | 2618.5 |
27 Mar 2025 | 2631.25 |
26 Mar 2025 | 2728 |
25 Mar 2025 | 2771.1 |
Company Fundamentals for Ajanta Pharma Ltd
Market Cap
31,126 Cr
EPS
71.9
P/E Ratio (TTM)
34.7
P/B Ratio (TTM)
8.5
Day’s High
2492.1
Day’s Low
2454.0
DTE
0.0
ROE
23.8
52 Week High
3485.75
52 Week Low
2022.05
ROCE
32.1
Market Price of Ajanta Pharma Ltd
1M
1Y
3Y
5Y
Ajanta Pharma Ltd News Hub
Ajanta Pharma fixes record date for interim dividend
Ajanta Pharma has fixed 06 November 2024 as record date for payment of interim dividend, if declared
Read more
23 Oct 24
Ajanta Pharma Ltd eases for fifth straight session
Ajanta Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 2974.35, do
Read more
23 Oct 24
Ajanta Pharma to hold board meeting
Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 28 October 2024. Power
Read more
17 Oct 24
Board of Ajanta Pharma recommends First Interim Dividend
Ajanta Pharma announced that the Board of Directors of the Company at its meeting held on 28 October
Read more
28 Oct 24
Document
Concalls